Complement structural imaging with biochemical data.
MR spectroscopy plays a critical role across a range of pediatric neurological conditions.
MRS provides critical insights into the dynamic biochemical changes within the injured brain, such as elevated lactate and decreased N-acetylaspartate (NAA), indicating oxygen deprivation and neuronal damage, respectively.
MRS can play a crucial role in unraveling the intricate biochemical changes occurring in the epileptic brain. Elevated lactate levels point to heightened metabolic activity during seizures, while shifts in N-acetylaspartate (NAA) concentrations may indicate neuronal dysfunction.
MRS can help characterize pediatric brain tumors by revealing distinct metabolic signatures, supporting tumor differentiation and potentially identifying molecular subtypes and early changes associated with progression or treatment response.
MRS metabolite profiles can reveal underlying metabolic abnormalities in children presenting with developmental delay, helping guide diagnosis and early intervention strategies.
Canavan disease (elevated NAA), mitochondrial encephalopathies (elevated lactate), and leukodystrophies each produce characteristic chemical signatures that MR spectroscopy detects.
MRS provides metabolic assessment of CNS involvement in chromosomal and neurocutaneous syndromes, complementing genetic diagnosis with metabolic information.